Mittal leads oversight for the industry-leading Novaplus® Enhanced Supply program, which gives Vizient members access to more than 100 million additional units of essential medications warehoused in the U.S. She leads a team that develops key strategic sourcing programs that focus on transparency, redundancy and commitment to support a resilient supply chain for essential medications, and to date, over a million doses of these critical medications have been accessed by health systems during a supply challenge.
Under Mittal’s direction, the Vizient pharmaceutical portfolio incorporates generic injectables, branded pharmaceuticals, plasma products, pharmacy distribution and the private-label Novaplus program. She also leads strategy and oversight of the Vizient Pharmacy Aggregation Groups, including the Vizient Oncology Network. Mittal also plays a pivotal role in advocacy related to drug shortages, 340B contract pharmacies and the unapproved drug initiative. She helped launch and is an advisory board member of the End Drug Shortages Alliance and chairs the Healthcare Supply Chain Association Pharmacy Committee.
During the COVID-19 pandemic, Mittal led a team that ensured hospital pharmacies had access to essential medications and COVID-19 supportive care treatments to treat their patients. This included collaboration with supplier partners and 503B entities yielding creative solutions that drove production of additional inventory.
With many years of leadership experience for Vizient’s expanding pharmacy program and contracting team, she’s held other positions within Vizient’s clinical solutions and sourcing teams, managing numerous programs, and contracting activities including the plasma program, contrast media and radiopharmacy distribution, and leading strategies for non-acute sector driving enhanced value for Vizient membership.
Prior to joining Vizient, Mittal served in various healthcare roles, which helped shape her unique perspective and comprehensive understanding of how her current work positively influences the healthcare industry.
Mittal holds a Doctor of Pharmacy degree from the University of Texas at Austin and a Business Foundations certification from McCombs School of Business at the University of Texas. Mittal was recognized among Women Leaders in Supply Chain in the Journal of Healthcare Contracting in 2020.